GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) » Definitions » Return-on-Tangible-Equity

Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) Return-on-Tangible-Equity : 6.51% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Asia Medical and Agricultural Laboratory and Research Center PCL's annualized net income for the quarter that ended in Jun. 2024 was ฿32.2 Mil. Asia Medical and Agricultural Laboratory and Research Center PCL's average shareholder tangible equity for the quarter that ended in Jun. 2024 was ฿494.4 Mil. Therefore, Asia Medical and Agricultural Laboratory and Research Center PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2024 was 6.51%.

The historical rank and industry rank for Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity or its related term are showing as below:

BKK:AMARC' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 1.89   Med: 8.9   Max: 17.8
Current: 4.07

During the past 5 years, Asia Medical and Agricultural Laboratory and Research Center PCL's highest Return-on-Tangible-Equity was 17.80%. The lowest was 1.89%. And the median was 8.90%.

BKK:AMARC's Return-on-Tangible-Equity is ranked worse than
55.59% of 2360 companies
in the Hardware industry
Industry Median: 5.44 vs BKK:AMARC: 4.07

Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity Historical Data

The historical data trend for Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity Chart

Asia Medical and Agricultural Laboratory and Research Center PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
- 17.80 13.75 4.05 1.89

Asia Medical and Agricultural Laboratory and Research Center PCL Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.17 4.67 0.14 4.93 6.51

Competitive Comparison of Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity

For the Scientific & Technical Instruments subindustry, Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity falls into.



Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity Calculation

Asia Medical and Agricultural Laboratory and Research Center PCL's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=9.644/( (526.789+492.996 )/ 2 )
=9.644/509.8925
=1.89 %

Asia Medical and Agricultural Laboratory and Research Center PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2024 )  (Q: Mar. 2024 )(Q: Jun. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Mar. 2024 )(Q: Jun. 2024 )
=32.172/( (498.896+489.943)/ 2 )
=32.172/494.4195
=6.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Asia Medical and Agricultural Laboratory and Research Center PCL  (BKK:AMARC) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Asia Medical and Agricultural Laboratory and Research Center PCL Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Asia Medical and Agricultural Laboratory and Research Center PCL's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Asia Medical and Agricultural Laboratory and Research Center PCL Business Description

Traded in Other Exchanges
N/A
Address
361 Soi Ladprao 122, Ladprao Road, Phlabphla, Wang Thonglang, Bangkok, THA, 10310
Asia Medical and Agricultural Laboratory and Research Center PCL is engaged in providing comprehensive scientific services for the agriculture, food, pharmaceutical and environment sectors including testing, calibration, inspection and certification according to international quality standards.

Asia Medical and Agricultural Laboratory and Research Center PCL Headlines

No Headlines